Cardinal Health Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Cardinal Health wird ein Gewinn- und Umsatzwachstum von 20.3% bzw. 2.6% pro Jahr prognostiziert, während der Gewinn pro Aktie um 22.5% pro Jahr wachsen soll.
Wichtige Informationen
20.5%
Wachstumsrate der Gewinne
23.0%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 17.1% |
| Wachstumsrate der Einnahmen | 2.6% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 11 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056
Jun 11
Cardinal Health's Valuation Makes The Name Unattractive
May 26Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
May 03Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk
Apr 14Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?
Mar 09Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues
Dec 28Cardinal Health Is Setting Up For A Great 2024
Dec 21Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate
Nov 03Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity
Oct 13Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
Aug 07Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue
Aug 05An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued
Jul 14Cardinal Health: Not A Long-Term Investment
May 24The Return Trends At Cardinal Health (NYSE:CAH) Look Promising
Apr 17Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price
Mar 30Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
Feb 21Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957
Feb 16Cardinal Health declares $0.4957 dividend
Feb 10Cardinal Health FQ2 2023 Earnings Preview
Feb 01Cardinal Health partners with Palantir for data-driven supply chain support
Jan 26Cardinal Health Is A Tempting Healthcare Income Play
Dec 28Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957
Dec 20Aaron Alt is the new finance chief at Cardinal health
Dec 19Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?
Dec 14Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Nov 16Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment
Nov 14Cardinal Health rises on Q1 earnings beat
Nov 04Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term
Oct 10Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Sep 29Cardinal Health: Aristocrat Heading For A Makeover
Sep 26PayrHealth to collaborate with Cardinal Health
Sep 15Cardinal Health in pact with activist investor Elliot for value creation measures
Sep 06Cardinal Health's (NYSE:CAH) Dividend Will Be $0.4957
Sep 01Activist interest in Cardinal Health could unlock value, improve margins - Morgan Stanley
Aug 16Is It Too Late To Consider Buying Cardinal Health, Inc. (NYSE:CAH)?
Aug 15Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 6/30/2026 | 226,846 | 1,605 | 2,080 | 2,582 | 13 |
| 6/30/2025 | 209,992 | 1,418 | 1,295 | 1,804 | 14 |
| 6/30/2024 | 225,710 | 951 | 2,011 | 2,510 | 15 |
| 3/31/2024 | 220,572 | 552 | 2,008 | 2,543 | N/A |
| 12/31/2023 | 216,148 | 639 | 3,421 | 3,953 | N/A |
| 9/30/2023 | 210,172 | 156 | 2,858 | 3,361 | N/A |
| 6/30/2023 | 205,012 | 261 | 2,358 | 2,839 | N/A |
| 3/31/2023 | 198,662 | 463 | 4,545 | 4,973 | N/A |
| 12/31/2022 | 193,011 | -1,273 | 2,792 | 3,193 | N/A |
| 9/30/2022 | 186,999 | -1,094 | 3,401 | 3,791 | N/A |
| 6/30/2022 | 181,364 | -933 | 2,735 | 3,122 | N/A |
| 3/31/2022 | 176,847 | -955 | 446 | 795 | N/A |
| 12/31/2021 | 171,286 | 555 | 1,124 | 1,491 | N/A |
| 9/30/2021 | 167,370 | 1,135 | 1,124 | 1,513 | N/A |
| 6/30/2021 | 162,467 | 611 | 2,029 | 2,429 | N/A |
| 3/31/2021 | 156,570 | 1,151 | 1,594 | 2,004 | N/A |
| 12/31/2020 | 156,452 | 1,382 | 3,003 | 3,403 | N/A |
| 9/30/2020 | 154,646 | 973 | 2,502 | 2,883 | N/A |
| 6/30/2020 | 152,922 | -3,696 | 1,585 | 1,960 | N/A |
| 3/31/2020 | 153,586 | -4,158 | 1,851 | 2,226 | N/A |
| 12/31/2019 | 149,657 | -4,212 | 1,669 | 2,030 | N/A |
| 9/30/2019 | 147,662 | -4,152 | 1,362 | 1,704 | N/A |
| 6/30/2019 | 145,534 | 1,363 | 2,394 | 2,722 | N/A |
| 3/31/2019 | 143,530 | 3 | 2,440 | 2,770 | N/A |
| 12/31/2018 | 141,935 | -39 | 1,712 | 2,044 | N/A |
| 9/30/2018 | 139,381 | 734 | 1,577 | 1,952 | N/A |
| 6/30/2018 | 136,809 | 256 | 2,384 | 2,768 | N/A |
| 3/31/2018 | 134,426 | 1,696 | 2,598 | 2,938 | N/A |
| 12/31/2017 | 132,614 | 1,823 | N/A | 1,986 | N/A |
| 9/30/2017 | 130,578 | 1,094 | N/A | 2,261 | N/A |
| 6/30/2017 | 129,976 | 1,288 | N/A | 1,184 | N/A |
| 3/31/2017 | 128,394 | 1,346 | N/A | 1,101 | N/A |
| 12/31/2016 | 127,236 | 1,351 | N/A | 2,218 | N/A |
| 9/30/2016 | 125,530 | 1,353 | N/A | 3,127 | N/A |
| 6/30/2016 | 121,546 | 1,427 | N/A | 2,971 | N/A |
| 3/31/2016 | 117,710 | 1,387 | N/A | 3,198 | N/A |
| 12/31/2015 | 112,423 | 1,366 | N/A | 2,937 | N/A |
| 9/30/2015 | 106,516 | 1,329 | N/A | 2,427 | N/A |
| 6/30/2015 | 102,531 | 1,212 | N/A | 2,540 | N/A |
| 3/31/2015 | 97,877 | 1,154 | N/A | 2,388 | N/A |
| 12/31/2014 | 93,928 | 1,104 | N/A | 2,550 | N/A |
| 9/30/2014 | 90,631 | 1,089 | N/A | 1,634 | N/A |
| 6/30/2014 | 91,084 | 1,163 | N/A | 2,524 | N/A |
| 3/31/2014 | 93,610 | 343 | N/A | 2,108 | N/A |
| 12/31/2013 | 96,735 | 374 | N/A | 2,277 | N/A |
| 9/30/2013 | 99,727 | 403 | N/A | 2,110 | N/A |
| 6/30/2013 | 101,093 | 335 | N/A | 1,727 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CAHDas prognostizierte Gewinnwachstum (20.3% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: CAHDie Erträge des Unternehmens (20.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.7% pro Jahr).
Hohe Wachstumserträge: CAHEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: CAHDie Einnahmen des Unternehmens (2.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.4% pro Jahr).
Hohe Wachstumseinnahmen: CAHDie Einnahmen des Unternehmens (2.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CAH in 3 Jahren voraussichtlich hoch sein wird